Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSFORM: Filgotinib vs IL-6 inhibitors in rheumatoid arthritis
jRCTs071200107Completed
- Sponsor
- Gilead Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of filgotinib in rheumatoid arthritis (RA) (2 arms), sponsored by Gilead Sciences. Primary endpoint: ACR50 response at week 12. Started May 2021; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on jRCTs071200107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200107.